Oxbryta Receives FDA Approval for Treating Sickle Cell Disease

[RobertReny]

On Monday, the U.S. Food and Drug Administration (FDA) announced accelerated approval of Oxbryta (voxelotor) for the treatment of sickle cell disease in patients aged 12 and above.

“Oxbryta is the first approved treatment for sickle cell disease that directly inhibits the root cause of the disease, sickle hemoglobin polymerization.”

Human trials were conducted on 274 patients with sickle cell disease, of which, 90 patients were given 1,500 mg Oxbryta, 92 patients were given 900 mg, while the remaining 92 patients were given a placebo.

After 24 weeks, more than 51 percent of patients who received Oxbryta 1,500 mg had a greater hemoglobin response when compared with only 6.5 percent of patients who were given a placebo.

Source:- bit.ly/35ICsWB

[baba360]

Hello Robert will Oxbryta, in time become available in the UK, specifically on the NHS.

[RobertReny in reply to baba360]

As if for now I don't have any update.

[Chibaby1]

When will it be available in Nigeria. Thank you Jesus and holyspirit

[RobertReny in reply to Chibaby1]

As if for now I don't have any update.

[Drivee in reply to Chibaby1]

Hello, have you by any chance gotten the drug now? I live in Nigeria too

[Drivee]

When will this be in Nigeria, and what range can the price be?

[RobertReny in reply to Drivee]

Not sure about the exact price, a lot of time and effort are put on this medicine. I don't think it is going to be affordable.

[Drivee in reply to RobertReny]

One more problem for the average sickler

[arinzemuo21]

I read an article online that it would be around $100,000 for a one year treatment and one has to take it for a lifetime. It is relatively expensive and that would be an issue on it's own.

[Drivee in reply to arinzemuo21]

Absolutely. It's a solution that births another entirely new problem!!!